Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy

Thyroid

Volumn 13, Issue 9, 2003, Pages 851-859

  Marinò, Michele ^a   Lisi, Simonetta ^a   Pinchera, Aldo ^a   Marcocci, Claudio ^a   Menconi, Francesca ^a   Morabito, Eugenia ^a   Macchia, Marco ^a   Sellari Franceschini, Stefano ^a   McCluskey, Robert T ^b   Chiovato, Luca ^c  

^a UNIVERSITY OF PISA   (Italy)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ARGININE; CHONDROITIN 6 SULFATE; DERMATAN SULFATE; GLUTAMIC ACID; GLYCOSAMINOGLYCAN; HEPARIN BINDING PROTEIN; HYALURONIC ACID; SODIUM CHLORIDE; THYROGLOBULIN;

ADULT; AGED; ARTICLE; ASSAY; BINDING AFFINITY; BINDING SITE; CLINICAL ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HUMAN; HUMAN TISSUE; IMMOBILIZATION; MALE; ORBIT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 12444331588     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072503322401041     Document Type: Article

References (24)

1. Bahn RS, Heufelder AE 1993 Pathogenesis of Graves' ophthalmopathy. N Engl J Med 329:1468-1475.
2. Burch HB, Wartofsky L 1993 Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endocr Rev 14:747-793.
3. Prummel MF 1999 Pathogenetic and clinical aspects of endocrine ophthalmopathy. Exp Clin Endocrinol Diabetes 107(Suppl 3):S75-78.
4. Ludgate M, Crisp M, Lane C, Costagliola S, Vassart G, Weetman A, Daunerie C, Many MC 1998 The thyrotropin receptor in thyroid eye disease. Thyroid 8:411-413.
5. Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE 1998 Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: Potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab 83:998-1002.
6. Agretti P, Chiovato L, De Marco G, Marocci C, Mazzi B, Sellan-Franceschini S, Vitti P, Pinchera A, Tonacchera M 2002. Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues. Eur J Endocrinol 147:733-739.
7. Macchia E, Concetti R, Borgoni F, Cetani F, Fenzi GF, Pinchera A 1989 Assays of TSH-receptor antibodies in 576 pafients with various thyroid disorders: Their incidence, significance and clinical usefulness. Autoimmunity 3:103-112.
8. Many MC, Costagliola S, Detrait M, Denef F, Vassart G, Ludgate MC 1999 Development of an animal model of autoimmune thyroid eye disease. J Immunol 162:4966-4974.
9. McDougall IR, Kriss JP 1974 New thoughts about the cause and treatment of the severe ocular manifestations of Graves' disease. Scott Med J 19:165-169.
10. Kriss JP 1970 Radioisotopic thyroidolymphography in patients with Graves' disease. J Clin Endocrinol Metab 31:315-323.
11. Mullin BR, Levinson RE, Friedman A, Henson DE, Winand RF, Kohn LD 1977 Delayed hypersensitivity in Graves' disease and exophthalmos: Identification of thyroglobulin in normal human orbital muscle. Endocrinology 100:351-366.
12. Marinò M, Lisi S, Pinchera A, Mazzi B, Latrofa F, Sellari-Franceschini S, McCluskey RT, Chiovato L 2001 Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy. Thyroid 11:177-185.
13. Lisi S, Marinò M, Pinchera A, Mazzi B, Di Cosmo C, Sellari-Franceschini S, Chiovato L 2002 Thyroglobulin in orbital tissues from patients with thyroid associated ophthalmopathy: Predominant localization in fibroadipose tissue. Thyroid 12:351-360.
14. Marinò M, Zheng G, McCluskey RT 1999 Megalin (gp330) is an endocytic receptor for thyroglobulin on cultured fisher rat thyroid cells. J Biol Chem 274:12898-12904.
15. Marinò M, Friedlander JA, McCluskey RT, Andrews D 1999 Identification of a heparin-binding region of rat thyroglobulin involved in megalin binding. J Biol Chem 274:30377-30386.
16. Marinò M, Andrews D, McCluskey RT 2000 Binding of rat thyroglobulin to heparan sulfate proteoglycans. Thyroid 10:551-559.
17. Lisi S, Pinchera A, McCluskey RT, Chiovato L, Marinò M 2002 Binding of heparin to human thyroglobulin (Tg) involves multiple binding sites including a region corresponding to a binding site of rat Tg. Eur J Endocrinol 146:591-602.
18. Marinò M, Zheng G, Chiovato L, Pinchera A, Brown D, Andrews D, McCluskey RT 2000 Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells: A novel function in the control of thyroid hormone release. J Biol Chem 275:7125-7138.
19. Rapaport B, McLachlan SM 2001 Keeping our eyes open. Thyroid 11:165-166.
20. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A 1998 Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338:73-78.
21. Pinchera A, Bartalena L, Marcocci C 1995 Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but .... J Clin Endocrinol Metab 80:342-345.
22. Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Pinchera A 1992 Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism. Thyroid 2:171-178.
23. Marcocci C, Bartalena L, Pinchera A 1998 Ablative or non-ablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy? J Endocrinol Invest 21:468-471.
24. Spencer CA 2000 Thyroglobulin. In: Braverman LE, Utiger R (eds) Werner and Ingebar's The Thyroid: A Fundamental and Clinical Text. Lippincott, Williams and Wilkins, Philadelphia, pp. 402-413.